The nine-month arcFrom one cell to forty weeks: germinal, embryonic, fetal
Before any teratogen enters the story, it helps to know the calendar it acts on. Prenatal development is conventionally divided into three periods that differ not in name only but in what is being built and, therefore, in what can go wrong.
The germinal period covers roughly the first two weeks after fertilization. A single-celled zygote divides as it travels down the fallopian tube, becoming a hollow ball of cells called a blastocyst that burrows into the uterine lining in the process of implantation (Moore et al., 2020). This period is biologically brutal and mostly invisible: a large share of conceptions — by many estimates half or more — never implant successfully or are lost before a pregnancy is even recognized, often because of chromosomal errors incompatible with development. Exposure during these first two weeks tends to follow an all-or-nothing pattern. Because the cells are still largely undifferentiated and interchangeable, a serious insult usually either kills the organism outright or is fully repaired as surviving cells take over, which is why the germinal period produces relatively few surviving malformations even though it is a time of heavy loss.
The embryonic period, spanning approximately weeks three through eight, is where the architecture of the body is laid down. In this window the primary germ layers differentiate and, through organogenesis, the heart begins to beat, the neural tube folds and closes to become the brain and spinal cord, and the limbs, eyes, and internal organs take shape (Moore et al., 2020). Precisely because so much structural building is compressed into so few weeks, the embryo is at its most vulnerable to structural birth defects now. Each organ keeps its own timetable, so the same exposure produces different malformations depending on which system happens to be forming that week — a fact that becomes the backbone of the timing principle discussed below.
The fetal period runs from about week nine until birth and is dominated by growth and maturation rather than the appearance of new structures. Organs already present grow larger and become functional, and the brain undergoes its most dramatic expansion, generating and connecting billions of neurons through the third trimester. Damage in this period is less likely to take the form of gross structural defects and more likely to compromise growth, the central nervous system, and later behavior. The idea that conditions in the womb during this long growth phase can set a trajectory for adult health — that low birth weight, for instance, foreshadows elevated risk of cardiovascular and metabolic disease decades later — is the core of the fetal-programming, or developmental-origins, hypothesis (Barker, 1990). It is also the clearest illustration of why prenatal harm can hide: the fetal brain can be altered in ways that leave no visible mark at birth.
The organizing frameStop memorizing teratogens — learn the principles
A teratogen is any agent — a drug, an infection, a pollutant, a maternal condition — capable of harming the developing embryo or fetus (the term comes from the Greek for "monster-maker," a relic of how dramatically some early-recognized cases presented). A bare list of teratogens — alcohol, tobacco, certain medications, rubella, mercury — is hard to reason from and impossible to keep current, because new exposures appear faster than any list can grow. The more powerful move is to learn the principles that govern how any agent does its damage. Modern teratology traces these generalizations to a set of principles articulated in the mid-twentieth century (Wilson, 1973), which can be distilled for a lifespan course into four ideas: dose, timing, individual susceptibility, and delayed emergence.
The dose–response principle holds that, as a rule, greater exposure produces greater risk, and for many teratogens no threshold has been proven genuinely safe. This is why guidance on alcohol in pregnancy is none rather than "a little is fine": no exposure level has been established below which the developing brain is reliably unharmed. The timing principle — arguably the most important for reasoning about defects — says that when an exposure occurs matters as much as what the exposure is. Because each organ has a narrow critical (or sensitive) period during organogenesis, the identical agent can be catastrophic one week and harmless the next. The textbook illustration is thalidomide, a sedative marketed to pregnant women for morning sickness in the late 1950s; it produced characteristic limb malformations only when taken during the specific window when the limbs were forming, so that the timing of a single dose, not merely its size, determined the outcome (McBride, 1961). Same molecule, different week, different — or no — defect.
The individual-susceptibility principle is a reminder that risk is probabilistic, not deterministic. Maternal and fetal genotype shape how a substance is absorbed, metabolized, and cleared, so an exposure that devastates one fetus may spare another — the nature-through-nurture logic of the whole course, playing out at the placenta. Finally, the principle of delayed, or "sleeper," effects warns that not all prenatal harm is visible at birth. Some exposures leave a newborn who looks entirely healthy, only for a learning disability, an attention problem, or a behavioral difficulty to surface years later when the affected systems are finally called on to perform. A reassuring delivery-room exam, in other words, cannot certify a clean slate.
1. Dose–response. Generally, more exposure means more risk. There's often no proven "safe" amount (this is why the advice on alcohol is none).
2. Critical/sensitive timing. When matters as much as what. During organogenesis (~weeks 3–8), organs are forming and are maximally vulnerable to structural defects; the same exposure later may harm growth or the brain instead. The zygote period is often all-or-nothing.
3. Individual susceptibility. Maternal and fetal genetics modify risk — the same exposure devastates one fetus and spares another. Nature-through-nurture, again.
4. Sleeper effects. Some damage isn't visible at birth. It can surface years later as a learning, attention, or behavioral problem — so a "normal" newborn doesn't rule out prenatal harm.
Apply the principles. Tap each to see it in action.
The clearest caseFetal alcohol spectrum disorders
No teratogen illustrates the four principles better than alcohol, and none is more consequential at the population level. The syndrome now called fetal alcohol syndrome was formally described in the English-language literature only in 1973, when a pattern of growth deficiency, a distinctive set of facial features, and central-nervous-system dysfunction was recognized among the children of mothers who drank heavily during pregnancy (Jones & Smith, 1973). That a teratogen this common went unnamed in medicine until the 1970s is a useful lesson in how recently much of this knowledge was assembled.
Today the umbrella term is fetal alcohol spectrum disorders (FASD), and the word spectrum does real work: outcomes range from the full syndrome, with its characteristic facial features and intellectual disability, to subtler alcohol-related neurodevelopmental deficits with no outward physical sign. Ethanol crosses the placenta freely and interferes with neuronal migration and survival, so the brain is vulnerable across all three trimesters, not just during organogenesis — which is why there is no safe trimester and no established safe dose. FASD is now understood to be strikingly common: a rigorous school-based study across four U.S. communities put conservative prevalence at roughly 1 to 5 percent of first-graders, higher than many long-standing estimates and comparable to or exceeding the prevalence of autism (May et al., 2018). That makes prenatal alcohol exposure one of the leading preventable causes of intellectual disability in the developed world.
What lifts FASD from a birth-defect footnote to a lifespan issue is its long tail. A prospective Seattle cohort followed individuals with FASD from birth into adolescence and adulthood and documented a pattern of secondary disabilities — disrupted schooling, trouble with the law, mental-health problems, and difficulty living independently — that accumulate across development well after the prenatal insult itself (Streissguth et al., 2004). Crucially, that same longitudinal work identified protective factors: an early diagnosis and a stable, nurturing caregiving environment substantially reduced the risk of adverse outcomes. This is the sleeper principle and the plasticity theme of the course in a single finding — the prenatal exposure sets the initial risk, but the postnatal environment meaningfully bends the trajectory.
Context updateThe abortion-access map after Dobbs
A strictly factual, evenhanded account of the current legal landscape — no position taken. This is context for understanding access to prenatal care and reproductive health services, which is what a development course cares about.
In June 2022, the U.S. Supreme Court decided Dobbs v. Jackson Women's Health Organization, overruling Roe v. Wade and returning the regulation of abortion to individual states (Dobbs v. Jackson Women's Health Organization, 2022). The result is a legal patchwork: some states protect access, others restrict or ban it, and the specifics keep shifting through legislation and litigation. Researchers have documented downstream, non-partisan effects worth knowing for a health course — for instance, changes in the availability of obstetric and prenatal care in some regions as clinics close or providers relocate, and longer travel distances to care in affected areas. The point here is not which policy is right; it's that the legal environment shapes prenatal-care access, and access shapes developmental outcomes. Keep this factual and balanced.
Why does a developmental-science course note this at all? Because the timing of and access to prenatal care are themselves developmental variables. Early and consistent prenatal care is associated with better detection of treatable complications and healthier outcomes, so anything that lengthens the distance to a provider or thins the local supply of obstetric services alters that access, quite apart from anyone's views on the underlying policy. The course's interest begins and ends there: the legal environment is one of the contextual forces — alongside poverty, insurance status, and geography — that shape the conditions into which a child is born. Those forces do not act on the fetus directly the way a molecule at the placenta does, but they determine whether the pregnancy is monitored, whether complications are caught, and how far a person must travel to be cared for safely.
Two modern exposuresThe opioid era and cannabis
The teratology principles are not a museum piece; two contemporary exposures show them operating in real time. Both also make the same uncomfortable point about the field — that a substance can be legal, common, or even marketed as "natural" and still carry real fetal risk.
The opioid era & NAS
As the opioid crisis grew, so did Neonatal Abstinence Syndrome (NAS) — newborns physically dependent on opioids taken during pregnancy, who go through withdrawal after birth: tremors, high-pitched crying, feeding trouble, poor sleep. NAS rates rose sharply over the 2000s–2010s. It's treatable, and it's a stark example of the dose–response and timing principles in a contemporary crisis.
Cannabis in pregnancy
As legalization spreads, prenatal cannabis use is rising — sometimes to manage nausea. But THC crosses the placenta, and evidence links prenatal exposure to lower birth weight and later attention and cognitive concerns. The American College of Obstetricians and Gynecologists advises against cannabis use in pregnancy and while breastfeeding. "Natural" is not the same as "safe for a fetus."
The opioid era turned a once-rare neonatal diagnosis into a national concern. As opioid prescribing and misuse climbed through the 2000s, hospitalizations for neonatal abstinence syndrome rose several-fold, and the associated health-care expenditures grew accordingly (Patrick et al., 2012). NAS is a genuine withdrawal syndrome: an infant who was physiologically dependent in utero must, once the umbilical supply is cut, clear the drug and readjust, producing tremors, high-pitched crying, sweating, feeding difficulty, and disrupted sleep. Clinical guidance frames the condition as identifiable and treatable, typically through supportive care and, when necessary, carefully tapered pharmacologic management (Hudak & Tan, 2012). NAS is also a clean demonstration of the dose and timing principles in a modern crisis: severity tends to track the pattern of exposure, and the syndrome itself is a consequence of exposure late enough in gestation to establish dependence.
Cannabis in pregnancy tests the "natural means safe" intuition directly. As legalization has spread and average potency has risen, prenatal cannabis use has increased, sometimes adopted specifically to manage nausea. But THC crosses the placenta and reaches the fetal bloodstream, and a large population-based study linked self-reported prenatal cannabis use to elevated risk of preterm birth and other adverse perinatal outcomes even after accounting for tobacco use and other factors (Corsi et al., 2019), with broader evidence pointing toward lower birth weight and later attention and cognitive concerns. On that basis the American College of Obstetricians and Gynecologists advises against cannabis use during pregnancy and lactation and encourages clinicians to recommend evidence-based alternatives for nausea (American College of Obstetricians and Gynecologists, 2017). The recurring theme is the sleeper principle: the most worrying cannabis-related outcomes are not dramatic malformations at birth but subtle, later-emerging differences in attention and cognition that a delivery-room exam cannot detect.
Among wealthy nations, the United States has an unusually high maternal-mortality rate. The starkest fact from CDC surveillance: Black women die from pregnancy-related causes at roughly three times the rate of White women — a disparity that persists across income and education levels, pointing to systemic factors in care rather than individual choices. A majority of these deaths are considered preventable by the review committees that examine them (Centers for Disease Control and Prevention, 2022). For a lifespan course, this is where "biology" meets "context": the safety of birth in America depends heavily on who is giving birth and where.
The most recent national surveillance sharpens the picture and complicates the simple "always rising" story. After a pandemic-era peak that pushed the U.S. maternal-mortality rate to 32.9 deaths per 100,000 live births in 2021, the national rate fell to 22.3 in 2022 and to about 17.9 by 2024 as COVID-19's contribution to maternal death receded (Hoyert, 2025). The racial disparity, however, did not close. In 2023 the rate for Black women was roughly 50 deaths per 100,000 live births — more than three times the rate of about 14 to 15 for White women — and Black women were the one group whose rate did not decline significantly (Hoyert, 2025). Two facts can be true at once: the national number has come down from its pandemic high, and the United States still records higher maternal mortality than peer nations along with a persistent, largely preventable racial gap. That combination is exactly why the topic belongs in a developmental-science course rather than only a policy one — the earliest environment a child can have is a pregnancy, and how safely that pregnancy ends is patterned by social forces, not biology alone.
The main eventLabor, delivery, and the first assessment
For all the attention prenatal risk receives, birth itself is a developmental event with its own physiology and its own hazards. Labor is conventionally divided into three stages. The first stage, by far the longest, is dilation: rhythmic uterine contractions thin (efface) and open the cervix, progressing from early labor to full dilation at about ten centimeters. The second stage is delivery — the pushing phase in which the baby moves through the birth canal and is born. The third stage is delivery of the placenta, or afterbirth, usually within a half hour of the baby (Moore et al., 2020). The whole sequence is a coordinated hormonal and mechanical process, and most of it is designed to unfold without intervention.
Immediately after delivery, the newborn's condition is summarized with the Apgar score, a quick five-item rating — heart rate, respiration, muscle tone, reflex response, and color — each scored 0, 1, or 2 for a total from 0 to 10, taken at one and five minutes of life (Apgar, 1953). The Apgar was never meant to predict long-term outcome; it is a rapid triage signal telling the delivery team whether a newborn needs help breathing or circulating right now, and a low one-minute score that rebounds by five minutes is common and usually reassuring. Its durability — still in universal use more than seventy years after its introduction — is a testament to the value of a simple, standardized bedside measure.
Birth does not always follow the textbook. When labor stalls, when the fetus is in distress, when the head is too large for the pelvis, or when the placenta obstructs the cervix, a cesarean delivery (surgical birth through the abdominal wall) may be the safer route; roughly a third of U.S. births now occur by cesarean. Other complications include preterm birth (before 37 weeks), which remains a leading contributor to infant mortality and to the developmental risks that follow immaturity, and anoxia — an interruption of oxygen during a difficult delivery that, if prolonged, can injure the brain. Understanding these complications is not morbid detail; it is the bridge between the prenatal chapter and the maternal-mortality problem that makes birth in the United States more dangerous than it should be.
The through-lineContext is a teratogen too
The organizing lesson of this unit is that prenatal development is neither pure biology nor pure environment but the two in constant negotiation. The four principles let you reason about any exposure — dose, timing, susceptibility, and delayed emergence — and each of the real-world cases here, from alcohol and opioids to cannabis, is those principles playing out in a specific historical moment. Just as important, the same plasticity that makes the embryo vulnerable to insult makes the child responsive to care: an early FASD diagnosis and a stable home change the odds (Streissguth et al., 2004), just as early prenatal care changes the odds at the other end of the pregnancy.
That is why a developmental-science account cannot stop at the placenta. Whether a pregnancy is reached by good care, whether a birth is attended safely, and whether the child's earliest environment is stable are all shaped by forces — economic, geographic, and legal — that sit outside the biology textbook yet act directly on the developing person. America's high and racially unequal maternal-mortality rate is the sharpest reminder that context is a teratogen too: the risks of pregnancy and birth are distributed not by nature alone but by who is giving birth and where. Holding the mechanism and the context together — the molecule at the placenta and the map of who can reach care — is what it means to think developmentally about the beginning of life.
SourcesCited in APA 7
American College of Obstetricians and Gynecologists. (2017). Marijuana use during pregnancy and lactation (Committee Opinion No. 722). Obstetrics & Gynecology, 130(4), e205–e209.
Apgar, V. (1953). A proposal for a new method of evaluation of the newborn infant. Current Researches in Anesthesia & Analgesia, 32(4), 260–267.
Barker, D. J. P. (1990). The fetal and infant origins of adult disease. BMJ, 301(6761), 1111.
Centers for Disease Control and Prevention. (2022). Pregnancy-related deaths: Data from Maternal Mortality Review Committees. U.S. Department of Health and Human Services.
Corsi, D. J., Walsh, L., Weiss, D., Hsu, H., El-Chaar, D., Hawken, S., Fell, D. B., & Walker, M. (2019). Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes. JAMA, 322(2), 145–152.
Dobbs v. Jackson Women's Health Organization, 597 U.S. 215 (2022).
Hoyert, D. L. (2025). Maternal mortality rates in the United States, 2023 (NCHS Health E-Stat). National Center for Health Statistics.
Hudak, M. L., & Tan, R. C. (2012). Neonatal drug withdrawal. Pediatrics, 129(2), e540–e560.
Jones, K. L., & Smith, D. W. (1973). Recognition of the fetal alcohol syndrome in early infancy. The Lancet, 302(7836), 999–1001.
May, P. A., Chambers, C. D., Kalberg, W. O., Zellner, J., Feldman, H., Buckley, D., Kopald, D., Hasken, J. M., Xu, R., Honerkamp-Smith, G., Taras, H., Manning, M. A., Robinson, L. K., Adam, M. P., Abdul-Rahman, O., Vaux, K., Jewett, T., Elliott, A. J., Kable, J. A., … Hoyme, H. E. (2018). Prevalence of fetal alcohol spectrum disorders in 4 US communities. JAMA, 319(5), 474–482.
McBride, W. G. (1961). Thalidomide and congenital abnormalities. The Lancet, 278(7216), 1358.
Moore, K. L., Persaud, T. V. N., & Torchia, M. G. (2020). The developing human: Clinically oriented embryology (11th ed.). Elsevier.
Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012). Neonatal abstinence syndrome and associated health care expenditures, United States, 2000–2009. JAMA, 307(18), 1934–1940.
Streissguth, A. P., Bookstein, F. L., Barr, H. M., Sampson, P. D., O'Malley, K., & Young, J. K. (2004). Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. Journal of Developmental and Behavioral Pediatrics, 25(4), 228–238.
Wilson, J. G. (1973). Environment and birth defects. Academic Press.